These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35760833)

  • 21. Mitochondrial Lon protease is a gatekeeper for proteins newly imported into the matrix.
    Matsushima Y; Takahashi K; Yue S; Fujiyoshi Y; Yoshioka H; Aihara M; Setoyama D; Uchiumi T; Fukuchi S; Kang D
    Commun Biol; 2021 Aug; 4(1):974. PubMed ID: 34400774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial Lon protease in human disease and aging: Including an etiologic classification of Lon-related diseases and disorders.
    Bota DA; Davies KJ
    Free Radic Biol Med; 2016 Nov; 100():188-198. PubMed ID: 27387767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial oxidative stress regulates LonP1-TDP-43 pathway and rises mitochondrial damage in carbon tetrachloride-induced liver fibrosis.
    Shan S; Liu Z; Wang S; Liu Z; Chao S; Zhang C; Li M; Song F
    Ecotoxicol Environ Saf; 2023 Oct; 264():115409. PubMed ID: 37647804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective mitochondrial protease LonP1 can cause classical mitochondrial disease.
    Peter B; Waddington CL; Oláhová M; Sommerville EW; Hopton S; Pyle A; Champion M; Ohlson M; Siibak T; Chrzanowska-Lightowlers ZMA; Taylor RW; Falkenberg M; Lightowlers RN
    Hum Mol Genet; 2018 May; 27(10):1743-1753. PubMed ID: 29518248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of mitochondrial LonP1 protease by allosteric blockade of ATP binding and hydrolysis via CDDO and its derivatives.
    Lee J; Pandey AK; Venkatesh S; Thilagavathi J; Honda T; Singh K; Suzuki CK
    J Biol Chem; 2022 Mar; 298(3):101719. PubMed ID: 35151690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease.
    Bai M; Wu M; Jiang M; He J; Deng X; Xu S; Fan J; Miao M; Wang T; Li Y; Yu X; Wang L; Zhang Y; Huang S; Yang L; Jia Z; Zhang A
    EMBO Mol Med; 2023 Feb; 15(2):e16581. PubMed ID: 36629048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrogen peroxide mediated mitochondrial UNG1-PRDX3 interaction and UNG1 degradation.
    Liu Z; Hu Y; Gong Y; Zhang W; Liu C; Wang Q; Deng H
    Free Radic Biol Med; 2016 Oct; 99():54-62. PubMed ID: 27480846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LONP1 and mtHSP70 cooperate to promote mitochondrial protein folding.
    Shin CS; Meng S; Garbis SD; Moradian A; Taylor RW; Sweredoski MJ; Lomenick B; Chan DC
    Nat Commun; 2021 Jan; 12(1):265. PubMed ID: 33431889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential Expression of Lonp1 Isoforms in Cancer Cells.
    Zanini G; Selleri V; De Gaetano A; Gibellini L; Malerba M; Mattioli AV; Nasi M; Apostolova N; Pinti M
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coordinated DNA polymerization by Polγ and the region of LonP1 regulated proteolysis.
    Riccio AA; Brannon AJ; Krahn JM; Bouvette J; Williams JG; Borgnia MJ; Copeland WC
    Nucleic Acids Res; 2024 Jul; 52(13):7863-7875. PubMed ID: 38932681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Akt phosphorylation of mitochondrial Lonp1 protease enables oxidative metabolism and advanced tumor traits.
    Ghosh JC; Seo JH; Agarwal E; Wang Y; Kossenkov AV; Tang HY; Speicher DW; Altieri DC
    Oncogene; 2019 Oct; 38(43):6926-6939. PubMed ID: 31406245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalytic cycling of human mitochondrial Lon protease.
    Mohammed I; Schmitz KA; Schenck N; Balasopoulos D; Topitsch A; Maier T; Abrahams JP
    Structure; 2022 Sep; 30(9):1254-1268.e7. PubMed ID: 35870450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LONP1 induction by SRT1720 attenuates mitochondrial dysfunction against high glucose induced neurotoxicity in PC12 cells.
    Kalvala AK; Yerra VG; Kumar A
    Toxicol In Vitro; 2020 Feb; 62():104695. PubMed ID: 31639451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial SSBP1 protects cells from proteotoxic stresses by potentiating stress-induced HSF1 transcriptional activity.
    Tan K; Fujimoto M; Takii R; Takaki E; Hayashida N; Nakai A
    Nat Commun; 2015 Mar; 6():6580. PubMed ID: 25762445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Context-dependent roles of mitochondrial LONP1 in orchestrating the balance between airway progenitor versus progeny cells.
    Xu L; Tan C; Barr J; Talaba N; Verheyden J; Chin JS; Gaboyan S; Kasaraneni N; Elgamal RM; Gaulton KJ; Lin G; Afshar K; Golts E; Meier A; Alexander LEC; Borok Z; Shen Y; Chung WK; McCulley DJ; Sun X
    Cell Stem Cell; 2024 Oct; 31(10):1465-1483.e6. PubMed ID: 39181129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity.
    Quirós PM; Español Y; Acín-Pérez R; Rodríguez F; Bárcena C; Watanabe K; Calvo E; Loureiro M; Fernández-García MS; Fueyo A; Vázquez J; Enríquez JA; López-Otín C
    Cell Rep; 2014 Jul; 8(2):542-56. PubMed ID: 25017063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mitochondrial FUNDC1/HSC70 interaction organizes the proteostatic stress response at the risk of cell morbidity.
    Li Y; Xue Y; Xu X; Wang G; Liu Y; Wu H; Li W; Wang Y; Chen Z; Zhang W; Zhu Y; Ji W; Xu T; Liu L; Chen Q
    EMBO J; 2019 Feb; 38(3):. PubMed ID: 30591555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LONP1-mediated mitochondrial quality control safeguards metabolic shifts in heart development.
    Zhao K; Huang X; Zhao W; Lu B; Yang Z
    Development; 2022 Mar; 149(6):. PubMed ID: 35237793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABCB10 depletion reduces unfolded protein response in mitochondria.
    Yano M
    Biochem Biophys Res Commun; 2017 Apr; 486(2):465-469. PubMed ID: 28315685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of LONP1 Suppresses Pancreatic Cancer Progression Via c-Jun N-Terminal Kinase Pathway-Meditated Epithelial-Mesenchymal Transition.
    Liu C; Wang H; Li H; Chen X; Wu X; Lu B; Zhang W; Zhou Y; Xiao GG; Gao G
    Pancreas; 2019; 48(5):629-635. PubMed ID: 31091208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.